期刊： DIABETES & METABOLISM, 2022; 48 (1)
Background and objectives: Type 2 diabetes mellitus (T2DM) patients with Coronavirus Disease 2019 (COVID19) have poorer prognosis. Inconclusive eviden......
期刊： DIABETES & METABOLISM, 2022; 48 (5)
Background: Glucagon-like peptide 1(GLP-1) receptor agonists are used in patients with type 2 diabetes as hypoglycemic drugs; a growing body of eviden......
期刊： DIABETES & METABOLISM, 2022; 48 (6)
Background: The relation of regular ibuprofen or paracetamol use with the risk of type 2 diabetes (T2DM) remained undetermined. We aimed to evaluate t......
期刊： DIABETES & METABOLISM, 2022; 48 (3)
Objective: More than one-third of chronic pancreatitis patients will eventually develop diabetes, recently classified as post-chronic pancreatitis dia......
期刊： DIABETES & METABOLISM, 2022; 48 (3)
Aims: Higher serum uric acid (UA) has been associated with increased risk of Type 2 diabetes mellitus. This cohort study examined whether there are an......
期刊： DIABETES & METABOLISM, 2022; 48 (5)
Aims: To investigate the association between metformin and bone mineral density (BMD) in a large cohort of Chinese patients with type 2 diabetes melli......
期刊： DIABETES & METABOLISM, 2022; 48 (3)
Objectives: : This study aimed to estimate the association between overweight and type 2 diabetes mellitus (T2DM) in twins, and further to explore whe......
期刊： DIABETES & METABOLISM, 2022; 48 (6)
Aim: Type 2 diabetes (T2DM) is closely related to nonalcoholic fatty liver disease (NAFLD) and is an important risk factor for the progression of live......
期刊： DIABETES & METABOLISM, 2022; 48 (1)
Aims: -Evidence for the effects of metabolically healthy obese (MHO) status on heart failure (HF) is limited and ignores the dynamic change of metabol......
期刊： DIABETES & METABOLISM, 2022; 48 (6)
Aims: Triglyceride-glucose (TyG) index has been proposed as a simple surrogate marker of insulin resistance. However, few studies have investigated th......
期刊： DIABETES & METABOLISM, 2022; 48 (6)
Aim: To investigate the relationship between circulating growth differentiation factor (GDF-15) levels and the risk of cardiovascular disease and canc......
期刊： DIABETES & METABOLISM, 2022; 48 (1)
Aims: To estimate the residual risk associations between hyperglycemia and adverse pregnancy outcomes after glycemia-controlling intervention. Methods......
期刊： DIABETES & METABOLISM, 2022; 48 (5)
Aims: China has the largest number of adults with diabetes. Although multiple metabolic risk factors (MRFs) are implicated in the development of diabe......
期刊： DIABETES & METABOLISM, 2022; 48 (6)
Aim: The organ protective effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors may be beneficial against infectious complications. This real-w......
